KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) EBITDA Margin (2017 - 2025)

Historic EBITDA Margin for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to 14.69%.

  • Elanco Animal Health's EBITDA Margin rose 81800.0% to 14.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.85%, marking a year-over-year increase of 379100.0%. This contributed to the annual value of 34.13% for FY2024, which is 366400.0% up from last year.
  • Latest data reveals that Elanco Animal Health reported EBITDA Margin of 14.69% as of Q3 2025, which was up 81800.0% from 17.81% recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's EBITDA Margin peaked at 20.87% during Q1 2025, and registered a low of 148.31% during Q3 2023.
  • Its 5-year average for EBITDA Margin is 41.02%, with a median of 48.53% in 2023.
  • In the last 5 years, Elanco Animal Health's EBITDA Margin plummeted by -980200bps in 2023 and then soared by 1548200bps in 2024.
  • Over the past 5 years, Elanco Animal Health's EBITDA Margin (Quarter) stood at 57.1% in 2021, then grew by 5bps to 54.52% in 2022, then decreased by -14bps to 62.13% in 2023, then rose by 13bps to 54.12% in 2024, then soared by 127bps to 14.69% in 2025.
  • Its EBITDA Margin was 14.69% in Q3 2025, compared to 17.81% in Q2 2025 and 20.87% in Q1 2025.